- Home
- AXSM vs HASI Comparison
AXSM vs HASI Comparison
Compare AXSM & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- HASI
- Stock Information
- Founded
- AXSM 2012
- HASI 1981
- Country
- AXSM United States
- HASI United States
- Employees
- AXSM N/A
- HASI N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- HASI Real Estate Investment Trusts
- Sector
- AXSM Health Care
- HASI Real Estate
- Exchange
- AXSM Nasdaq
- HASI Nasdaq
- Market Cap
- AXSM 5.1B
- HASI 3.4B
- IPO Year
- AXSM 2015
- HASI 2013
- Fundamental
- Price
- AXSM $108.98
- HASI $27.20
- Analyst Decision
- AXSM Strong Buy
- HASI Strong Buy
- Analyst Count
- AXSM 17
- HASI 9
- Target Price
- AXSM $171.65
- HASI $38.33
- AVG Volume (30 Days)
- AXSM 636.2K
- HASI 1.8M
- Earning Date
- AXSM 08-04-2025
- HASI 07-31-2025
- Dividend Yield
- AXSM N/A
- HASI 6.15%
- EPS Growth
- AXSM N/A
- HASI N/A
- EPS
- AXSM N/A
- HASI 1.08
- Revenue
- AXSM $432,157,000.00
- HASI $126,702,000.00
- Revenue This Year
- AXSM $62.84
- HASI $189.49
- Revenue Next Year
- AXSM $60.02
- HASI $14.03
- P/E Ratio
- AXSM N/A
- HASI $25.27
- Revenue Growth
- AXSM 72.16
- HASI N/A
- 52 Week Low
- AXSM $72.21
- HASI $21.98
- 52 Week High
- AXSM $139.13
- HASI $36.56
- Technical
- Relative Strength Index (RSI)
- AXSM 56.00
- HASI 54.56
- Support Level
- AXSM $102.26
- HASI $26.36
- Resistance Level
- AXSM $114.66
- HASI $27.92
- Average True Range (ATR)
- AXSM 3.49
- HASI 0.81
- MACD
- AXSM 0.92
- HASI 0.03
- Stochastic Oscillator
- AXSM 61.89
- HASI 63.64
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.